Tirzepatide vs GHRP-6

A comprehensive, data-driven comparison of Tirzepatide (Mounjaro) and GHRP-6 (Growth Hormone Releasing Peptide-6). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.

Tirzepatide
FDA Approved
Type 2 diabetes, chronic weight management, and obstructive sleep apnea
Evidence
High
Avg. Weight Loss22.5%
Monthly Cost$1,100 - $1,100/mo
DosingWeekly
ManufacturerEli Lilly
GHRP-6
Not submitted
Growth hormone optimization
Evidence
Emerging
Monthly Cost$35 - $70/mo
DosingDaily

Side-by-Side Comparison

PropertyTirzepatide
Mounjaro, Zepbound
GHRP-6
Growth Hormone Releasing Peptide-6
FDA Status
FDA Approved
Not submitted
Category
Weight Loss
Growth Hormone
Primary Use
Type 2 diabetes, chronic weight management, and obstructive sleep apnea
Growth hormone optimization
Weight Loss %
22.5%
N/A
Monthly Cost
$1,100 - $1,100/mo
$35 - $70/mo
Administration
Subcutaneous injection
Subcutaneous injection
Typical Dose
15mg weekly (max dose)
100-300mcg 2-3x daily
Frequency
Weekly
Daily
Mechanism

Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric emptying, and decreases appetite

First-generation growth hormone secretagogue that stimulates GH release and increases appetite via ghrelin mimicry

Common Side Effects
  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • +3 more
  • Significant increase in appetite
  • Water retention
  • Tingling or numbness
  • Fatigue
  • +1 more
Serious Side Effects
  • Pancreatitis
  • Hypoglycemia
  • Acute gallbladder disease
  • Hypersensitivity reactions
  • +1 more
  • Elevated cortisol
  • Elevated prolactin
  • Insulin resistance
Evidence Quality
High
Emerging
Clinical Trial Phase
Approved
N/A

Key Differences

  • 1Tirzepatide is FDA-approved, while GHRP-6 is currently not submitted.
  • 2Tirzepatide has clinical weight loss data (22.5%), while GHRP-6 is not primarily indicated for weight loss.
  • 3GHRP-6 is generally more affordable ($35 - $70/mo) compared to Tirzepatide ($1,100 - $1,100/mo).
  • 4Tirzepatide is dosed weekly, while GHRP-6 is daily.
  • 5Tirzepatide has high-quality evidence, while GHRP-6 has emerging-quality evidence.
  • 6They belong to different categories: Tirzepatide (Weight Loss) vs GHRP-6 (Growth Hormone).

Which Is Better For...

TI

Tirzepatide

Those seeking an FDA-approved treatment with established safety data

GH

GHRP-6

More budget-friendly option with lower monthly costs

TI

Tirzepatide

More convenient dosing schedule (weekly)

GH

GHRP-6

Fewer commonly reported side effects

TI

Tirzepatide

Stronger clinical evidence base to support its use

Cost Comparison

PeptideMonthly Cost RangeFDA StatusManufacturer
Tirzepatide$1,100 - $1,100/mo
FDA Approved
Eli Lilly
GHRP-6$35 - $70/mo
Not submitted
Various research labs

Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.

Frequently Asked Questions

What is the main difference between Tirzepatide and GHRP-6?

Tirzepatide works via Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric. GHRP-6 works via First-generation growth hormone secretagogue that stimulates GH release and increases appetite via. They differ in FDA approval status, efficacy data, and cost.

Which is more effective for weight loss, Tirzepatide or GHRP-6?

Tirzepatide has demonstrated 22.5% average weight loss in clinical trials. GHRP-6 is not primarily used for weight loss.

How much does Tirzepatide cost compared to GHRP-6?

Tirzepatide typically costs $1,100 - $1,100/mo, while GHRP-6 costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.

Are Tirzepatide and GHRP-6 FDA approved?

Tirzepatide is FDA-approved. GHRP-6 is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.

What are the side effects of Tirzepatide vs GHRP-6?

Common side effects of Tirzepatide include Nausea, Diarrhea, Decreased appetite. Common side effects of GHRP-6 include Significant increase in appetite, Water retention, Tingling or numbness. Always consult a healthcare provider about potential side effects.

Can I switch from Tirzepatide to GHRP-6?

Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.

Learn More

Tirzepatide Full Profile
Type 2 diabetes, chronic weight management, and obstructive sleep apnea

Tirzepatide is a dual-action peptide approved by the FDA as Mounjaro for type 2 diabetes and Zepbound for weight management. In December 2024, Zepbound became the first and only medication approved fo...

View Full Tirzepatide Guide
GHRP-6 Full Profile
Growth hormone optimization

GHRP-6 is a synthetic hexapeptide and one of the first growth hormone releasing peptides developed. It stimulates GH secretion by activating the ghrelin receptor. Unlike later-generation peptides like...

View Full GHRP-6 Guide

Other Popular Comparisons

Medical Disclaimer

The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Tirzepatide and GHRP-6 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.